UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 259

Sortiert nach

Functional role of ADAMTS5 in adiposity and metabolic health

PloS one, 2018-01, Vol.13 (1), p.e0190595-e0190595

2018

Volltextzugriff (PDF)

The European NAFLD Registry: A real-world longitudinal cohort study of nonalcoholic fatty liver disease

Contemporary clinical trials, 2020-11, Vol.98, p.106175-106175, Article 106175

2020

Volltextzugriff (PDF)

Performance of the PRO-C3 collagen neo-epitope biomarker in non-alcoholic fatty liver disease

JHEP reports, 2019-09, Vol.1 (3), p.188-198

2019

Volltextzugriff (PDF)

Practical diagnosis of cirrhosis in non-alcoholic fatty liver disease using currently available non-invasive fibrosis tests

Nature communications, 2023-08, Vol.14 (1), p.5219-5219, Article 5219

2023

Volltextzugriff (PDF)

Erratum: FTY720/fingolimod decreases hepatic steatosis and expression of fatty acid synthase in diet-induced nonalcoholic fatty liver disease in mice

Journal of lipid research, 2020-02, Vol.61 (2), p.267-267

2020

Volltextzugriff (PDF)

At similar weight loss, dietary composition determines the degree of glycemic improvement in diet-induced obese C57BL/6 mice

PloS one, 2018-07, Vol.13 (7), p.e0200779-e0200779

2018

Volltextzugriff (PDF)

Author Correction: The Transcriptomic Signature Of Disease Development And Progression Of Nonalcoholic Fatty Liver Disease

Scientific reports, 2020-05, Vol.10 (1), p.8374-8374, Article 8374

2020

Volltextzugriff (PDF)

Accumulation of Intrahepatic TNF-a-Producing NKp44 NK Cells Correlates With Liver Fibrosis and Viral Load in Chronic HCV Infection

Medicine (Baltimore), 2016-05, Vol.95 (19)

2016

Volltextzugriff (PDF)

Increased serum miR-193a-5p during non-alcoholic fatty liver disease progression: Diagnostic and mechanistic relevance

JHEP reports, 2022-02, Vol.4 (2), p.100409-100409, Article 100409

2022

Volltextzugriff (PDF)

Prospective comparison of transient elastography, MRI and serum scores for grading steatosis and detecting non-alcoholic steatohepatitis in bariatric surgery candidates

JHEP reports, 2021-12, Vol.3 (6), p.100381-100381, Article 100381

2021

Volltextzugriff (PDF)

Clinical Interest of Serum Alpha-2 Macroglobulin, Apolipoprotein A1, and Haptoglobin in Patients with Non-Alcoholic Fatty Liver Disease, with and without Type 2 Diabetes, before or during COVID-19

Biomedicines, 2022-03, Vol.10 (3), p.699

2022

Volltextzugriff (PDF)

Current histological classification of NAFLD: strength and limitations

Hepatology international, 2013-12, Vol.7 (Suppl 2), p.765-770

Bedossa, Pierre

2013

Volltextzugriff (PDF)

Utility and appropriateness of the fatty liver inhibition of progression (FLIP) algorithm and steatosis, activity, and fibrosis (SAF) score in the evaluation of biopsies of nonalcoholic fatty liver disease: BEDOSSA ET AL

Hepatology (Baltimore, Md.), 2014-08, Vol.60 (2), p.565-575

Bedossa, Pierre

2014

Volltextzugriff (PDF)

An Improved qFibrosis Algorithm for Precise Screening and Enrollment into Non-Alcoholic Steatohepatitis (NASH) Clinical Trials

Diagnostics (Basel), 2020-08, Vol.10 (9), p.643

2020

Volltextzugriff (PDF)

Accuracy of FibroScan Controlled Attenuation Parameter and Liver Stiffness Measurement in Assessing Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease

Gastroenterology (New York, N.Y. 1943), 2019-05, Vol.156 (6), p.1717-1730

2019

Volltextzugriff (PDF)

Enhanced liver fibrosis test for the non-invasive diagnosis of fibrosis in patients with NAFLD: A systematic review and meta-analysis

Journal of hepatology, 2020-08, Vol.73 (2), p.252-262

2020

Volltextzugriff (PDF)

Clinical validation of the FLIP algorithm and the SAF score in patients with non-alcoholic fatty liver disease

Journal of hepatology, 2020-05, Vol.72 (5), p.828-838

2020

Volltextzugriff (PDF)

Liver fibrosis: consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL)

Hepatology international, 2009-06, Vol.3 (2), p.323-333

2009

Volltextzugriff (PDF)

A Comparison of Three Interferon Alfa-2b Regimens for the Long-Term Treatment of Chronic Non-A, Non-B Hepatitis

The New England journal of medicine, 1995-06, Vol.332 (22), p.1457-1463

1995

Volltextzugriff (PDF)

A novel monoclonal antibody for detection of galectin-9 in tissue sections: application to human tissues infected by oncogenic viruses

Infectious agents and cancer, 2012-07, Vol.7 (1), p.16-16, Article 16

2012

Volltextzugriff (PDF)

WED-262 AI-assisted, quantitative digital pathology-based continuous fibrosis scores perform better than conventional pathology in documenting fibrosis reduction

Journal of hepatology, 2024-06, Vol.80, p.S533-S533

2024

Volltextzugriff (PDF)

An algorithm for the grading of activity in chronic hepatitis C

Hepatology (Baltimore, Md.), 1996-08, Vol.24 (2), p.289-293

1996

Volltextzugriff (PDF)

Cirrhosis Regression and Subclassification

Surgical pathology clinics, 2013-06, Vol.6 (2), p.295-309

2013

Volltextzugriff (PDF)

Telangiectatic adenoma: a variant of hepatocellular adenoma

Annals of hepatology, 2004-10, Vol.3 (4), p.163

Bedossa, Pierre

2004

Volltextzugriff (PDF)

1 – 25 von 259

Suche als RSS-Feed

Aktive Filter

KollektionMEDLINE

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(223)
Mit Volltextzugriff
(231)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(8)

Menü

Weitere Dienste

Einstellungen

Functional role of ADAMTS5 in adiposity and metabolic health

The European NAFLD Registry: A real-world longitudinal cohort study of nonalcoholic fatty liver disease

Performance of the PRO-C3 collagen neo-epitope biomarker in non-alcoholic fatty liver disease

Practical diagnosis of cirrhosis in non-alcoholic fatty liver disease using currently available non-invasive fibrosis tests

Metabolomic‐based noninvasive serum test to diagnose nonalcoholic steatohepatitis: Results from discovery and validation cohorts

Erratum: FTY720/fingolimod decreases hepatic steatosis and expression of fatty acid synthase in diet-induced nonalcoholic fatty liver disease in mice

At similar weight loss, dietary composition determines the degree of glycemic improvement in diet-induced obese C57BL/6 mice

Author Correction: The Transcriptomic Signature Of Disease Development And Progression Of Nonalcoholic Fatty Liver Disease

Accumulation of Intrahepatic TNF-a-Producing NKp44 NK Cells Correlates With Liver Fibrosis and Viral Load in Chronic HCV Infection

Increased serum miR-193a-5p during non-alcoholic fatty liver disease progression: Diagnostic and mechanistic relevance

Prospective comparison of transient elastography, MRI and serum scores for grading steatosis and detecting non-alcoholic steatohepatitis in bariatric surgery candidates

Clinical Interest of Serum Alpha-2 Macroglobulin, Apolipoprotein A1, and Haptoglobin in Patients with Non-Alcoholic Fatty Liver Disease, with and without Type 2 Diabetes, before or during COVID-19

Current histological classification of NAFLD: strength and limitations

Utility and appropriateness of the fatty liver inhibition of progression (FLIP) algorithm and steatosis, activity, and fibrosis (SAF) score in the evaluation of biopsies of nonalcoholic fatty liver disease: BEDOSSA ET AL

An Improved qFibrosis Algorithm for Precise Screening and Enrollment into Non-Alcoholic Steatohepatitis (NASH) Clinical Trials

Accuracy of FibroScan Controlled Attenuation Parameter and Liver Stiffness Measurement in Assessing Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease

Enhanced liver fibrosis test for the non-invasive diagnosis of fibrosis in patients with NAFLD: A systematic review and meta-analysis

Clinical validation of the FLIP algorithm and the SAF score in patients with non-alcoholic fatty liver disease

Liver fibrosis: consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL)

A Comparison of Three Interferon Alfa-2b Regimens for the Long-Term Treatment of Chronic Non-A, Non-B Hepatitis

A novel monoclonal antibody for detection of galectin-9 in tissue sections: application to human tissues infected by oncogenic viruses

WED-262 AI-assisted, quantitative digital pathology-based continuous fibrosis scores perform better than conventional pathology in documenting fibrosis reduction

An algorithm for the grading of activity in chronic hepatitis C

Cirrhosis Regression and Subclassification

Telangiectatic adenoma: a variant of hepatocellular adenoma

Aktive Filter

Suchergebnisse filtern